Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Impax Laboratories Inc (NASDAQ:IPXL)

Delayed Data
As of Mar 27
 +3.45 / +37.30%
Today’s Change
Today|||52-Week Range
Impax Gains 38% On CEO Appointment, Talk of Sale
Mar 27 / TheStreet.com - Paid Partner Content
Skincare Makers Lead Biotech Movers
Mar 27 / TheStreet.com - Paid Partner Content
Mid-Morning Market Update: Markets Open Lower; G-III Apparel Misses Q4 Views
Mar 27 / Benzinga - Paid Partner Content
Falling Earnings Estimates Signal Weakness Ahead for Impax Laboratories (IPXL)
Mar 22 / Zacks.com - Paid Partner Content